EUVIMEDEUVIMED entdecken
Crossref

Medidas de resultado y de la experiencia informadas (PROM/PREM) en una cohorte de pacientes ventilados con Distrofia Miotónica tipo 1: Protocolo del ESTUDIO PROEMSTEINERT

ML Lafarga Poyo, A Ortega González, A Gil Fuentes, MS Estrada Pastor, M Artero Clemente, S Granados Sotelo, A Camacho Nieto, AC Marín-Guerrero

Salux: revista de ciencias y humanidades · 02.11.2025 · 11 (20) · 5

DOI: 10.66423/qjra6545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Salux: revista de ciencias y humanidades, online erschienen am 02.11.2025. Verfasst von ML Lafarga Poyo und 7 weiteren Autor:innen. Die Arbeit nennt 133 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myotonic dystrophy type 1 (DM1) is a hereditary neuromuscular disease characterized by progressive respiratory dysfunction that may require home mechanical ventilation (HMV). This disease is frequently associated with cognitive and behavioral impairments, which hinder symptom awareness and, consequently, treatment adherence. Despite its clinical relevance, the factors contributing to poor treatment adherence in DM1 are not well defined. Material and methods: A prospective observational study is proposed in patients with DM1 aged over 16 and under 80 years who are candidates for initiating HMV. Over a 36-month follow up period, patient-reported outcome and experience measures (PROM and PREM) will be analyzed, along with variables related to therapeutic adherence and prognosis (survival from the start of HMV and number of hospital admissions).

Discussion

PROM and PREM scales have been recently validated in users of respiratory therapies and may provide key insights into the patient experience and engagement with treatment. In DM1, where disease awareness may be impaired, their application could be particularly useful for identifying adherence barriers and establishing individualized strategies.

Conclusions

This study will evaluate the utility of PROM and PREM in DM1 patients receiving HMV, exploring their association with treatment adherence and prognosis, which may have relevant implications for the clinical management of this population.

Zitieren

APA

Poyo, M. L., González, A. O., Fuentes, A. G., Pastor, M. E., Clemente, M. A., Sotelo, S. G., Nieto, A. C., & Marín-Guerrero, A. (2025). Medidas de resultado y de la experiencia informadas (PROM/PREM) en una cohorte de pacientes ventilados con Distrofia Miotónica tipo 1: Protocolo del ESTUDIO PROEMSTEINERT. Salux: revista de ciencias y humanidades, 11(20), 5. https://doi.org/10.66423/qjra6545

Vancouver

Poyo ML, González AO, Fuentes AG, Pastor ME, Clemente MA, Sotelo SG, et al. Medidas de resultado y de la experiencia informadas (PROM/PREM) en una cohorte de pacientes ventilados con Distrofia Miotónica tipo 1: Protocolo del ESTUDIO PROEMSTEINERT. Salux: revista de ciencias y humanidades. 2025;11(20):5. doi:10.66423/qjra6545

BibTeX
@article{Poyo2025,
  author = {Poyo, ML Lafarga and González, A Ortega and Fuentes, A Gil and Pastor, MS Estrada and Clemente, M Artero and Sotelo, S Granados and Nieto, A Camacho and Marín-Guerrero, AC},
  title = {Medidas de resultado y de la experiencia informadas (PROM/PREM) en una cohorte de pacientes ventilados con Distrofia Miotónica tipo 1: Protocolo del ESTUDIO PROEMSTEINERT},
  journal = {Salux: revista de ciencias y humanidades},
  year = {2025},
  volume = {11},
  number = {20},
  pages = {5},
  doi = {10.66423/qjra6545}
}
Kostenlos starten →